Related references
Note: Only part of the references are listed.Mechanisms of Sensitivity and Resistance to CDK4/6 Inhibition
Monica Alvarez-Fernandez et al.
CANCER CELL (2020)
Cell cycle plasticity driven by MTOR signaling: integral resistance to CDK4/6 inhibition in patient-derived models of pancreatic cancer
Erik S. Knudsen et al.
ONCOGENE (2019)
p27 allosterically activates cyclin-dependent kinase 4 and antagonizes palbociclib inhibition
Keelan Z. Guiley et al.
SCIENCE (2019)
Surprising regulation of cell cycle entry
Charles J. Sherr
SCIENCE (2019)
Structural insights into the functional diversity of the CDK-cyclin family
Daniel J. Wood et al.
OPEN BIOLOGY (2018)
Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway
Zhiqiang Li et al.
CANCER CELL (2018)
TGF-β Family Signaling in the Control of Cell Proliferation and Survival
Yun Zhang et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Cell-Cycle Therapeutics Come of Age
Matthew Ingham et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Mechanisms of Resistance to CDK4/6 Inhibitors in Breast Cancer and Potential Biomarkers of Response
Cristina Guarducci et al.
BREAST CARE (2017)
Targeting CDK4 and CDK6: From Discovery to Therapy
Charles J. Sherr et al.
CANCER DISCOVERY (2016)
Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression
Yuliya V. Katlinskaya et al.
CELL REPORTS (2016)
Brk/Protein Tyrosine Kinase 6 Phosphorylates p27KIP1, Regulating the Activity of Cyclin D-Cyclin-Dependent Kinase 4 (Publication with Expression of Concern. See vol. 42, 2022)
Priyank Patel et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
Cyclin-dependent kinases
Marcos Malumbres
GENOME BIOLOGY (2014)
Switching ceyclin D-Cdk4 kinase activity on and off
Stacy W. Blain
CELL CYCLE (2008)
Differential modification of p27(Kip1) controls its cyclin D-cdk4 inhibitory activity
Melissa K. James et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Share Paper
